Omega Pharma Forecasts Flat Turnover

Omega Pharma has reported a 10% fall in H109 profit and a 3% decline in turnover to US$442mn, but forecasts a flat turnover for the full year. Despite the decline in earnings in H109, BMI believes the company's expansion into emerging markets such as the Czech Republic, Argentina, India and Mexico and its interest in countries such as Romania, Bulgaria and countries of the former Yugoslavia and Soviet Union will prove to be a successful

To read the full article, please choose one of the following options: